Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Vanden Bempt M"'
Autor:
Vanden Bempt M; Laboratory for Experimental Hematology, Department of Oncology, KU Leuven, Leuven, Belgium.; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Debackere K; Laboratory for Experimental Hematology, Department of Oncology, KU Leuven, Leuven, Belgium.; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Demeyer S; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Van Thillo Q; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Meeuws N; Laboratory for Experimental Hematology, Department of Oncology, KU Leuven, Leuven, Belgium.; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Prieto C; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Provost S; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Mentens N; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Jacobs K; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Gielen O; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Nittner D; Histopathology Expertise Center, VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Ogawa S; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kataoka K; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Graux C; Department of Hematology, Mont-Godinne University Hospital, Yvoir, Belgium., Tousseyn T; Translational Cell & Tissue Research, KU Leuven, Leuven, Belgium.; Department of Pathology, University Hospital Leuven, Leuven, Belgium., Cools J; Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven, Leuven, Belgium.; VIB- Katholieke Universiteit Leuven Center for Cancer Biology, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium., Dierickx D; Laboratory for Experimental Hematology, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuvens Kanker Instituut, KU Leuven-UZ Leuven, Leuven, Belgium.; Department of Hematology, University Hospital Leuven, Leuven, Belgium.
Publikováno v:
Blood [Blood] 2022 Dec 08; Vol. 140 (23), pp. 2463-2476.
Autor:
Vanden Bempt, M
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological disease, which arises from the malignant transformation of developing T-cell progenitors. Survival rates are nowadays up to 90% in children and 40% in adults. However, current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1131::cabd282b1b7fe711232883e4592c56c4
https://lirias.kuleuven.be/handle/123456789/628448
https://lirias.kuleuven.be/handle/123456789/628448
Autor:
Debackere K; Laboratory for Experimental Hematology, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium., Marcelis L; Translational Cell & Tissue Research, KU Leuven, Leuven, Belgium., Demeyer S; Center for Cancer Biology, VIB, Leuven, Belgium.; Center for Human Genetics, KU Leuven, Leuven, Belgium., Vanden Bempt M; Laboratory for Experimental Hematology, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium.; Center for Human Genetics, KU Leuven, Leuven, Belgium., Mentens N; Center for Cancer Biology, VIB, Leuven, Belgium.; Center for Human Genetics, KU Leuven, Leuven, Belgium., Gielen O; Center for Cancer Biology, VIB, Leuven, Belgium.; Center for Human Genetics, KU Leuven, Leuven, Belgium., Jacobs K; Center for Cancer Biology, VIB, Leuven, Belgium.; Center for Human Genetics, KU Leuven, Leuven, Belgium., Broux M; Center for Cancer Biology, VIB, Leuven, Belgium.; Center for Human Genetics, KU Leuven, Leuven, Belgium., Verhoef G; Laboratory for Experimental Hematology, KU Leuven, Leuven, Belgium.; Department of Hematology, University Hospitals Leuven, Leuven, Belgium., Michaux L; Center for Human Genetics, KU Leuven, Leuven, Belgium.; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium., Graux C; Mont-Godinne University Hospital, Yvoir, Belgium., Wlodarska I; Center for Human Genetics, KU Leuven, Leuven, Belgium.; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium., Gaulard P; Département de Pathologie, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France.; INSERM U955 and Université Paris-Est, Créteil, France., de Leval L; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland., Tousseyn T; Translational Cell & Tissue Research, KU Leuven, Leuven, Belgium.; Department of Pathology, University Hospitals Leuven, Leuven, Belgium., Cools J; Center for Cancer Biology, VIB, Leuven, Belgium. jan.cools@kuleuven.be.; Center for Human Genetics, KU Leuven, Leuven, Belgium. jan.cools@kuleuven.be., Dierickx D; Laboratory for Experimental Hematology, KU Leuven, Leuven, Belgium. daan.dierickx@uzleuven.be.; Department of Hematology, University Hospitals Leuven, Leuven, Belgium. daan.dierickx@uzleuven.be.
Publikováno v:
Nature communications [Nat Commun] 2021 Jun 17; Vol. 12 (1), pp. 3705. Date of Electronic Publication: 2021 Jun 17.
Autor:
Bassez A; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Vos H; Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Van Dyck L; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Floris G; Department of Imaging & Pathology, Laboratory of Translational Cell & Tissue Research and Department of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Arijs I; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Boeckx B; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Vanden Bempt M; VIB Center for Cancer Biology, Leuven, Belgium., Nevelsteen I; Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Lambein K; Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Punie K; Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Neven P; Department of Gynaecology and Obstetrics, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Garg AD; Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium., Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Qian J; Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China. dr_qian@zju.edu.cn., Smeets A; Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. Ann.Smeets@uzleuven.be., Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium. Diether.Lambrechts@vib-kuleuven.be.; VIB Center for Cancer Biology, Leuven, Belgium. Diether.Lambrechts@vib-kuleuven.be.
Publikováno v:
Nature medicine [Nat Med] 2021 May; Vol. 27 (5), pp. 820-832. Date of Electronic Publication: 2021 May 06.
Autor:
Xie, Wei1 (AUTHOR), Bao, Zhongming2 (AUTHOR), Yao, Dan3 (AUTHOR), Yang, Yong4 (AUTHOR) yangyongdoc@163.com
Publikováno v:
Cell Division. 9/11/2024, Vol. 19 Issue 1, p1-15. 15p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xia, Xueting1 (AUTHOR), Yang, Zongxin1 (AUTHOR), Lu, Qisi2,3 (AUTHOR), Liu, Zhenyun4 (AUTHOR), Wang, Lei4 (AUTHOR), Du, Jinwen4 (AUTHOR), Li, Yuhua4 (AUTHOR) liyuhua2011gz@163.com, Yang, Dong-Hua5 (AUTHOR) dong-hua.yang@nyctcm.edu, Wu, Shaojie4 (AUTHOR) wshj510515@163.com
Publikováno v:
Molecular Cancer. 8/26/2024, Vol. 23 Issue 1, p1-21. 21p.
Autor:
Fu, Xiaoying1 (AUTHOR), Guo, Xiaoyan2 (AUTHOR), Xu, Han1 (AUTHOR), Li, Yini3 (AUTHOR), Jin, Bihui1 (AUTHOR), Zhang, Xirong4 (AUTHOR), Shu, Chongyi1 (AUTHOR), Fan, Yuhang1 (AUTHOR), Yu, Yiqi1 (AUTHOR), Tian, Yuqing1 (AUTHOR), Tian, Jiao2 (AUTHOR), Shu, Jing1,2,5 (AUTHOR) shujing@hmc.edu.cn
Publikováno v:
Reproductive Biology & Endocrinology. 7/31/2024, Vol. 22 Issue 1, p1-15. 15p.
Autor:
Bullock, Kennady K.1 (AUTHOR) kennady.k.bullock@vanderbilt.edu, Richmond, Ann1 (AUTHOR) ann.richmond@vanderbilt.edu
Publikováno v:
Cancers. Jun2024, Vol. 16 Issue 12, p2189. 26p.
Autor:
Chang, Esther Wei Yin1,2 (AUTHOR) esther.chang.w.y@singhealth.com.sg, Tan, Ya Hwee1,2 (AUTHOR), Chan, Jason Yongsheng1,2,3 (AUTHOR) jason.chan.y.s@singhealth.com.sg
Publikováno v:
Journal of Hematology & Oncology. 6/1/2024, Vol. 17, p1-20. 20p.